About 7.4 million obese Americans could have insurance coverage for drugs like Ozempic and Wegovy if the Trump administration ...

Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top ...

Insurers could save 20% in administrative costs and 10% in medical costs by harnessing the technology, experts said during a ...

CVS, Cigna and UnitedHealth are suing the Federal Trade Commission in a bid to block the agency’s lawsuit against their pharmacy benefit managers for allegedly inflating U.S. insulin prices.

A Texas federal judge has sided with UnitedHealthcare in determining regulators messed up calculating its Medicare Advantage ...

contextflow’s AI-driven technology enables radiologists to track lung nodules over time, assess malignancy, and generate high ...

AI could ease labor shortages, but health systems will need to increase cybersecurity spending to manage heightened risks, ...

Mike Pykosz, who joined CVS with its acquisition of the value-based medical chain in 2023, is departing amid a flurry of high ...

Major drugmakers are filing lawsuits against the HHS and HRSA to try to resuscitate plans to issue hospitals rebates instead ...

“RFK Jr. has championed issues like healthy foods and the need for greater transparency in our public health infrastructure,” ...

Mass General Brigham, Emory and other providers will assess different AI models from companies like Google, Microsoft and ...